SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

ASLAN Pharmaceuticals Earlier Reported Q1 EPS $(0.020) Up From $(0.030) YoY

ASLAN Pharmaceuticals (NASDAQ:ASLN) reported quarterly losses of $(0.020) per share. This is a 33.33 percent increase over losses of $(0.030) per share from the same period last year.

Benzinga · 05/11/2020 15:04

ASLAN Pharmaceuticals (NASDAQ:ASLN) reported quarterly losses of $(0.020) per share. This is a 33.33 percent increase over losses of $(0.030) per share from the same period last year.